Records containing: Juvenile Dermatomyositis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
-
CLINICAL_TRIALS study record update · 2026-04-23Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis
-
CLINICAL_TRIALS study record update · 2026-04-20Environmental Risk Factors for the Anti-Synthetase Syndrome
-
CLINICAL_TRIALS study record update · 2026-04-08Descartes-08 for Children, Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus, ANCA-associated Vasculitis, Juvenile Myasthenia Gravis, and Juvenile Dermatomyositis
-
CLINICAL_TRIALS study record update · 2026-04-06Studies of Natural History, Pathogenesis, and Outcomes in Autoimmune and Inflammatory Diseases Including Juvenile Dermatomyositis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-01Comparison Of The Effects Of Two Different Exercise Training Based On Internal And External Focus In Children and Adolescents With Rheumatic Diseases
-
CLINICAL_TRIALS study record update · 2026-02-11TRACER: Transition to Adulthood Through Coaching and Empowerment in Rheumatology, A Feasibility Study
-
CLINICAL_TRIALS study record update · 2026-01-28MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) - A Qualitative Study of Patient-voiced Research Priorities Across Rare Myositis Diseases
-
CLINICAL_TRIALS study record update · 2025-08-28Fitness Integrative Training for Pediatric Rheumatology Disorders (FIT Teens II): a Pilot Feasibility Study
-
CLINICAL_TRIALS study record update · 2024-08-26Clinical Study of CD19 Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Refractory Juvenile Dermatomyositis (RJDM)
-
CLINICAL_TRIALS study record update · 2024-06-11Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
-
CLINICAL_TRIALS study record update · 2022-08-19Clinical Analysis of 12 Cases of Juvenile Dermatomyositis Treated With Methylprednisolone Repeated Intermittent Pulse Combined With Mycophenolate Mofetil
-
CLINICAL_TRIALS study record update · 2021-03-16Five-year Single-blind, Phase III Effectiveness Randomised Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis: Prednisone Versus Prednisone Plus Cyclosporine a Versus Prednisone Plus Methotrexate
-
CLINICAL_TRIALS study record update · 2019-04-26Evaluation of Yellow Fever Vaccine in Patients With Rheumatic Diseases Under Low Immunosuppression Level and Residing in a Risk Area
-
CLINICAL_TRIALS study record update · 2018-05-11The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis
-
CLINICAL_TRIALS study record update · 2018-02-27Retrospective Descriptive Study of Juvenile Dermatomyositis in Alsace
-
CLINICAL_TRIALS study record update · 2018-02-14Incidence and Prevalence of Juvenile Dermatomyositis in Alsace Between 2000 to 2015
-
CLINICAL_TRIALS study record update · 2017-11-13Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease
-
CLINICAL_TRIALS study record update · 2015-11-17The CARRA Registry
-
CLINICAL_TRIALS study record update · 2015-03-04Rituximab Therapy in Refractory Adult and Juvenile Idiopathic Inflammatory Myopathy (IIM)
-
CLINICAL_TRIALS study record update · 2012-01-16Efficacy and Safety of Creatine Supplementation in Patients With Juvenile Systemic Lupus Erythematosus and Juvenile Dermatomyositis